Synapse Biomedical Debuts Diaphragm Pacer, HDE-Cleared To Aid Breathing

Synapse Biomedical will pursue expanded approval of its diaphragm pacing system to facilitate breathing in patients with Lou Gehrig's disease after gaining a humanitarian device exemption June 17 for use by ventilator-dependent spinal cord injury patients, according to the company

More from Archive

More from Medtech Insight